The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Oct. 29, 2010
Applicants:

Young-guen Kwon, Seoul, KR;

Young-ger Suh, Seoul, KR;

Inventors:

Young-Guen Kwon, Seoul, KR;

Young-Ger Suh, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07J 41/00 (2006.01); C07J 17/00 (2006.01); A01N 45/00 (2006.01); A61K 31/59 (2006.01); A61K 31/58 (2006.01); A61K 31/56 (2006.01); C07D 309/12 (2006.01); C07D 239/34 (2006.01); C07D 309/30 (2006.01); C07D 309/10 (2006.01); C07D 303/22 (2006.01);
U.S. Cl.
CPC ...
C07D 309/12 (2013.01); C07D 239/34 (2013.01); C07D 309/30 (2013.01); C07D 309/10 (2013.01); C07D 303/22 (2013.01); C07J 17/00 (2013.01);
Abstract

The present disclosure relates to a novel vascular leakage inhibitor. The novel vascular leakage inhibitor of the present disclosure inhibits the apoptosis of vascular endothelial cells, inhibits the formation of actin stress fibers induced by VEGF, enhances the cortical actin ring structure, and improves the stability of the tight junctions (TJs) between vascular cells, thereby inhibiting vascular leakage. The vascular leakage inhibitor of the present disclosure has the activity of not only reducing vascular permeability but also recovering the integrity of damaged blood vessels. Accordingly, the vascular leakage inhibitor of the present disclosure can prevent or treat various diseases caused by vascular leakage. Since the vascular leakage inhibitor of the present disclosure is synthesized from commercially available or easily synthesizable cholesterols, it has remarkably superior feasibility of commercial synthesis.


Find Patent Forward Citations

Loading…